InVivo Therapeutics Holdings Corp., a company developing technologies for the treatment of spinal cord injuries and neurotrauma, said it held a ribbon cutting ceremony Tuesday for its new headquarters office at One Kendall Square in Cambridge.
The new quarters will house the company’s office, manufacturing, and lab space in a 21,000-square-foot facility, InVivo said. The company’s 34 employees were previously located at several small offices, including offices at the Cambridge Innovation Center. At the new office, all the company’s employees will be consolidated under one roof, a company spokeswoman said.
The company was founded in 2005 based on proprietary technology co-invented by Robert S. Langer, a professor at the Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital.
In 2009, InVivo Therapeutics received $500,000 in early-stage loan financing through the accelerator program of the Massachusetts Life Sciences Center, the agency charged with implementing the Commonwealth’s 10-year, $1 billion Life Sciences Initiative.
The initiative is a priority of Governor Deval Patrick, who issued a statement to take note of InVivo’s ribbon-cutting ceremony.
“With our support, InVivo Therapeutics is growing our innovation economy while fostering local talent,” Patrick said. “I look forward to seeing them create further jobs and opportunities in the Commonwealth.”